Christina Friese: Characterization of tumor-infiltrating lymphocytes after checkpoint blockade within the tumor microenvironment of tumor fragments
Marie Christine Wulf Westergaard: Characterization of tumor-infiltrating lymphocytes and the tumor microenvironment in patients with ovarian cancer
Sara Ram Pedersen, MSc: Characterization of immunoregulatory mechanisms in the tumor microenvironment
Morten Nielsen, MD: In vitro expansion of tumour-infiltrating lymphocytes from sarcoma
Dorota Ewa Kuczek, MSc: The immunomodulatory effects of the extracellular matrix
Magnus Pedersen, MD: Adoptive Cell Therapy Regimens with Tumor-Infiltrating Lymphocytes in Ovarian Cancer and Renal Cell Carcinoma
Evelina Martinenaite, MSc.: Preventing immune inhibition in cancer: characterization of immune responses against immune regulatory proteins
Gitte Holmen Olofsson, MSc.: Vγ9Vδ2 T cells as cancer cell killers and antigen presenting cells
Troels Holz Borch, MD: Evaluation of immune responses to dendritic cell vaccination and adoptive cell therapy
Morten Orebo Holmström, MD: Targeting the Shared Neoantigens: Potentials of Cancer Immune Therapy in Chronic
Rikke Andersen, MD: Exploiting tumor-infiltrating lymphocytes for the treatment of cancer
Manja Idorn, MSc.: Genetic Engineering of T cells for Improved Homing to Tumor Site - Optimizing Adoptive Cell Therapy
Shamaila Munir Ahmad, cand.scient.: T-cell responses
against PD-L1 protein in cancer patients.
Per Kongsted, MD: Taxane-based chemotherapy and dendritic cell therapy in metastatic castration-resistant prostate cancer.
Jon Bjørn, MD: Ipilimumab in the treatment of metastatic malignant melanoma. Immunological correlates of treatment and combination therapy.
Thomas Mørch Frøsig, cand.scient.pharm.: Elucidating the immunological effects of 5-Azacytidine treatment in patients with myelodysplastic syndrome and identifying new conditional ligands and T-cell epitopes of relevance in melanoma.
Caroline Hasselbalch Riley, MD.: Immunological phenotype in patients with JAK2 V617F-positive chronic myeloproliferative neoplasms. Impact of immune therapy with IFN-alpha.
Mads Duus Hjortsø, cand.scient.: T-cell Recognition of Immune Modulatory Molecules in Cancer
Stine Kiær Larsen, cand. scient.: Cellular Immune Responses Towards Regulatory Cells
Marco Donia, MD: Methods to improve Adoptive T cell therapy with tumor infiltrating lymphocytes
Rikke Sick Andersen, cand. scient.: Dissection of human melanoma specific T-cell immunity by use of combinatorial encoding MHC multimers
Trine Zeeberg Iversen, MD: Immune Modulations during Chemo-Immunotherapy & Novel Vaccine Strategies - In Metastatic Melanoma and Non Small-Cell Lung Cancer
Tania Køllgaard, cand. scient.: Immune regulatory cells and polymorphisms in cancer
Eva Ellebæk, MD: Dendritic cell vaccination and adoptive cell therapy in patients with metastatic malignant melanoma
Anne Ortved Gang, MD: Immune modulatory effects of azacytidine and possible implications for immunotherapy
Lotte Engell-Nørregård, MD: Dendritic cell vaccination of patients with metastatic malignant melanoma
Niels Junker, MD: Ex vivo expansion and characterization of tumor infiltrating lymphocyte derived T effector memory cells from malignant melanoma and oral squamous cell carcinoma